Universidad de Valladolid, Spain : Inserm U. 188, Paris. Somatomedin and transferrin in celiac disease (CD).
Sulfation activity (Sm) and transferrin (Tf) were measured in 90 plasma samples from 39 children with CD classified 5 to 1 by intestinal biopsy performed at time of sampling : 10 before, 58 during gluten-free diet (GF), 22 after gluten reintroduction (GR). Sm was 0.32 ± 0.04 U/ml before GF, increased with GF from stages 5 to 1, to reach 1.23 ± 0.15, decreased at GR to 0.38 : 0.06. Sm correlated to GF duration (r =0.781).
Correlation of Sm with growth velocity (V) was lacking at stages 5 to 2, and appeared at stage 1 (r = 0.778).
Tf decreased from a high value of 3.62 ± 0.15 gil at stage 5 to 2.97 ± 0.14 after GF at stage 1, rising to 3.35 : 0.10 at GR. Tf correlated negatively with GF duration (r = -0.720) and positively to V on GF (r = 0.492) and GR (r = 0.601) • Longitudinal studies from GF to GR and again GF confirmed the inverse trend of sm and Tf variations. These data show that early catch-up growth in CD treated with GF does not relate to sulfation activity and may involve other factorl\r such as Tf. Random plasma somatomedln-C levels were measured In 101 children aged 7 months to 18 years with growth at or below the 5th percentile. 87 of 101 had short stature due to constitutional delay or genetic predisposition and 14 were growth hormone deficient. In the short nonnal group mean somatomedln-C levels were: 0-2 years: 0.22i D.D2U/ml; 2-5 years: 0.28tD.06U/ml; 5-12 years: D.78tO.1U/ml; 12-18 years: 1.22tO.16U/ml; compared with D.23tO.04U/ml In the growth hormone deficient children. 55 of 101 had somatomedln-C levels of D.5U/ml, and had one or more growth hormone stimulation tests. All 14 growth hormone deficient patients fell Into this group (range: D.09-0.47U/ml). The 41 nonnal patients In this group (growth hormone 6ng/ml) were dlstlbuted alllOllg the entire 87 normals as follows: 0-2 years: 10/10; 2-5 years: 19/23; 5-12 years: 11130; 12-18 years: 1/24. There was considerable overlap of values among growth hormone deficient and short normal children under 12 years of age, but a clear separation above 12 years. In 5 of 6 patients In whom 2 measurements were made, there were major dl fferences In these levels. 1) Random somatomedln-C levels lack specIficity In screenlpg for growth hormone deficiency under the age of 12 years.
2) The variation of levels In IndIvidual petlents necessitates further study to Identify a possible diurnal or pulsatile secretory pattern. 3) A standardized time of s.mpllng should be considered.
DepartllHlnta
Drugs commonlr used to treat children with acute lymphoblastic leukaemia were inveatigated in vitro to determine cartilage responsiveness to somatomedin using the uptake of radioactive sulphate and thymidine br porcine cartilage.
Prednisolone and doxorubicin profoundlr deprese cartilage reeponeiveness at doses within therapeutic ranges and vincrietine and crtosine arabinoside produce leeser but significant inhibition.
Using rat liver perfueioneit was poeeible to demonstrate that growth-hormone stimulated liver~duction of somatomedin activitr is profoundlr depreased br vinc etine and ():mercaptopurine, is lowered br crclophosphemide and crtosine arabinoeide but ie unaffected br prednisol'ne and doxorubicin.
The poor growth of children with ALL during treatment~be mediated br a drug-induced combination of diminished eomatomedin production and cartilage response to somatomedin. R. ROSENFELD,. S. KEMP. and R. HINTZ. Dept. of Pediatrics, Stanford University, Stanford, California. Acute and chronic somatomedin-C response to growth hormone: evaluation of correlation with age and growth rate.
The correlation between acute and chronic SM-C responses to hGH treatment of hypopituitary dws.rfism, and their value in predicting growth rates were studied in 20 GH-deficient children. SM-C by RIA and RRA was measured prior to hGH, 12 hours after 4 daily injections of hGH, 0.1 U/kg, and after 6 months of hGH 0.1 U/kg t.i. The correlation between SM-C by RRA and RIA was highly significant (r-0.92 on Day 1 and at 6 months, p <0.001). The acute SM-C response to hGH was predictive of chronic SM-C levels (Day 5 vs. 6 month SM-C, r-0.80, p <0.001). However, individual SM-C responses were variable, with 7 children achieving SM-C levels >1 U/ml by Day 5, while 3 maintained levels < 0.10 U/ml. Although the annual growth rate increased from 3.6 + 0.1 to 6.7 + 0.6 cm/yr, no correlation was observed between growth rate and baseline, acute or chronic SM-C levels. Children under 10 years of age had the smallest increment in SM-C, but the best growth rate. However, even when subdivided by age, no correlation was observed between 6 month SM-C and growth rates (r-O.IO, p >0.75). We conclude that (1) the acute SM-C response to hGH predicts chronic SM-C levels, (2) SM-C and growth response to hGH are age-dependent and (3) the level of SM-C elevation with hGH cannot predict growth response.
Effects of fasting and refeeding on grbwth hormone receptors inrat liver membranes.
The mechanism of the growth defect often associated with poor nutrition is not clear. We have studied the specific binding of growth hormone (GH) to liver membranes of 3 groups of rats which were (F) fasted for 4 days, (R) refed for 3 days after fasting,~a (controls) allowed free access to food. The specific binding of 125I-BGH (bovine GH) was low in microsomal membranes of (F) rats :
